Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Reid

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Public Health Reviews|October 21, 2022
ASPHER Statement: Facing the Fourth Winter of the COVID-19 PandemicRok Hrzic, Nadav Davidovitch, Henrique Barros, et al.
Nature Communications|May 25, 2021
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymeraseRobert P Hayes, Mee Ra Heo, Mark Mason, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet Singh Majhail, James Douglas Rizzo, Stephanie Joi Lee, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 9, 2023
Core competencies in applied infectious disease epidemiology: a framework for countries in EuropeAmelie Plymoth, Mary B Codd, Julia Barry, et al.
Journal of Medicinal Chemistry|October 12, 2011
Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptaseRobert Gomez, Samson J Jolly, Theresa Williams, et al.
Public Health Reviews|May 22, 2024
The COVID-19 Pandemic as a Public Health Teacher-the Lessons We Must LearnSofia Lombatti, Avi Magid, Nadav Davidovitch, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
Human Mutation|May 21, 2019
Integration of multiple epigenomic marks improves prediction of variant impact in saturation mutagenesis reporter assayDustin Shigaki, Orit Adato, Aashish N Adhikari, et al.
The Lancet. Neurology|October 18, 2024
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trialKeith W Muir, Gary A Ford, Ian Ford, et al.
British Journal of Haematology|June 14, 2021
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantationCarolyn M Mulroney, Muhammad Bilal Abid, Asad Bashey, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Public Health Reviews|October 21, 2022
ASPHER Statement: Facing the Fourth Winter of the COVID-19 PandemicRok Hrzic, Nadav Davidovitch, Henrique Barros, et al.
Nature Communications|May 25, 2021
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymeraseRobert P Hayes, Mee Ra Heo, Mark Mason, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet Singh Majhail, James Douglas Rizzo, Stephanie Joi Lee, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 9, 2023
Core competencies in applied infectious disease epidemiology: a framework for countries in EuropeAmelie Plymoth, Mary B Codd, Julia Barry, et al.
Journal of Medicinal Chemistry|October 12, 2011
Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptaseRobert Gomez, Samson J Jolly, Theresa Williams, et al.
Public Health Reviews|May 22, 2024
The COVID-19 Pandemic as a Public Health Teacher-the Lessons We Must LearnSofia Lombatti, Avi Magid, Nadav Davidovitch, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
Human Mutation|May 21, 2019
Integration of multiple epigenomic marks improves prediction of variant impact in saturation mutagenesis reporter assayDustin Shigaki, Orit Adato, Aashish N Adhikari, et al.
The Lancet. Neurology|October 18, 2024
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trialKeith W Muir, Gary A Ford, Ian Ford, et al.
British Journal of Haematology|June 14, 2021
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantationCarolyn M Mulroney, Muhammad Bilal Abid, Asad Bashey, et al.
Pageof 12